Gallipoli, P., Shepherd, P., Irvine, D., Drummond, M. and Holyoake, T. (2011) Restricted access to second generation tyrosine kinase inhibitors in the UK could result in suboptimal treatment for almost half of chronic myeloid leukaemia patients: results from a West of Scotland and Lothian population study. British Journal of Haematology, 155(1), pp. 128-130. (doi: 10.1111/j.1365-2141.2011.08653.x)
Full text not currently available from Enlighten.
Publisher's URL: http://dx.doi.org/10.1111/j.1365-2141.2011.08653.x
Abstract
No abstract available.
Item Type: | Articles (Letter) |
---|---|
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Drummond, Dr Mark and Holyoake, Professor Tessa and Gallipoli, Dr Paolo and Irvine, Dr David |
Authors: | Gallipoli, P., Shepherd, P., Irvine, D., Drummond, M., and Holyoake, T. |
College/School: | College of Medical Veterinary and Life Sciences > School of Cancer Sciences |
Journal Name: | British Journal of Haematology |
Journal Abbr.: | Brit. J. Haematol. |
Publisher: | Blackwell |
ISSN: | 0007-1048 |
ISSN (Online): | 1365-2141 |
Published Online: | 22 April 2011 |
Related URLs: |
University Staff: Request a correction | Enlighten Editors: Update this record